Oviva, the health tech startup that provides a digital solution for Type 2 diabetes treatment in Europe, has raised $21 million in Series B funding. Leading the round is MTIP, with participation by new investor Earlybird and existing investors AlbionVC, F-Prime Capital, Eight Roads Ventures and Partech. Oviva says the new capital will be used … Continue reading Oviva scores $21M Series B to bring its digital diabetes treatment to more of Europe